Effects of cutaneous leishmaniasis on patients' quality of life.
Cutaneous leishmaniasis
Lay gayint
Quality of life
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
18 Jun 2024
18 Jun 2024
Historique:
received:
28
02
2024
accepted:
17
06
2024
medline:
19
6
2024
pubmed:
19
6
2024
entrez:
18
6
2024
Statut:
epublish
Résumé
Cutaneous Leishmaniasis (CL) is caused by protozoan parasite called Leishmania. It is endemic in more than 100 countries globally. Despite its vast prevalence and impact on quality of life, it is one of the most neglected tropical dermatological diseases. The CL burden has often been expressed based on the physical disfigurement caused by the disease. However, considering the impact of the disease beyond physical impairment and changes in patients' appearance would help to better understand the disease as a public health problem. The effect of CL on patients' quality of life was determined in this study. The data that were related to quality of life were collected using Standard one-week Dermatology Life Quality Index (DLQI) questionnaire. The questions were categorized under seven domains: symptoms & feelings, daily activities, work and school, leisure, personal relationships, and treatment. Each question was scored on a three-point scale: Very much (3), A lot (2), A little (1), Undecided (0), and Not at all (0). The sum of the scores lied between 0 and 48. A higher score shows worse quality of life. The data were entered and analysed using Statistical Package for Social Science 23. Frequencies and proportions were used to describe the data. Differences were considered statistically significant at p < 0.05. The lives of the majority of CL patients (60.7%) were significantly affected by CL. The quality of life of patients was moderately impacted by CL in 25% of the CL patients. In 32.1% of the CL patients, the effect of CL on patients' quality of life was very large. The quality of one CL patient's life was extremely largely affected. The disease had a small effect on 32.1% of the CL patients. Personal relationship was the most affected domain followed by symptoms and feelings and treatment. Future study including rural regions is required. The Dermatology Life Quality Index demonstrates that CL has a small to extremely very large negative effect on the quality of life of patients.
Identifiants
pubmed: 38890616
doi: 10.1186/s12879-024-09518-3
pii: 10.1186/s12879-024-09518-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
598Informations de copyright
© 2024. The Author(s).
Références
Ruiz-Postigo JA, Grout L, Jain S. Global leishmaniasis surveillance, 2017–2018, and first report on 5 additional indicators weekly. Epidemiol Record. 2020;25:165–280.
Dostalova A, Volf P. Leishmania development in sand flies: parasite-vector interactions overview. Parasit Vectors. 2012;5:276.
doi: 10.1186/1756-3305-5-276
pubmed: 23206339
pmcid: 3533922
Steverding D. The history of leishmaniasis. Parasit Vectors. 2017;10(1):82.
doi: 10.1186/s13071-017-2028-5
pubmed: 28202044
pmcid: 5312593
Guideline for Diagnosis. Treatment and Prevention of Leishmaniasis in Ethiopia 2013.
Shita EY, Nibret E, Munshea A, Gashaw B. Burden and risk factors of cutaneous leishmaniasis in Ethiopia: a systematic review and meta-analysis. Int J Dermatol. 2022;61(11):1336–45.
doi: 10.1111/ijd.16265
pubmed: 35569096
Endalew Yizengaw EN, Gizachew Yismaw B, Gashaw D, Tamiru A, Munshea, Yegnasew Takele IM, Lloyd Chapman R, Weller JA, Cotton. Pascale Kropf. Cutaneous leishmaniasis in a newly established treatment centre in the Lay Gayint district, Northwest Ethiopia. Skin Health Disease. 2023:1–8.
Dassoni F, Daba F, Naafs B, Morrone A. Leishmaniasis recidivans in Ethiopia: cutaneous and mucocutaneous features. J Infect Dev Ctries. 2017;11(1):106–10.
doi: 10.3855/jidc.8516
pubmed: 28141598
Deribe K, Meribo K, Gebre T, Hailu A, Ali A, Aseffa A, Davey G. The burden of neglected tropical diseases in Ethiopia, and opportunities for integrated control and elimination. Parasit Vectors. 2012;5:240.
doi: 10.1186/1756-3305-5-240
pubmed: 23095679
pmcid: 3551690
Sunyoto T, Verdonck K, El Safi S, Potet J, Picado A, Boelaert M. Uncharted territory of the epidemiological burden of cutaneous leishmaniasis in sub-saharan Africa-A systematic review. PLoS Negl Trop Dis. 2018;12(10):e0006914.
doi: 10.1371/journal.pntd.0006914
pubmed: 30359376
pmcid: 6219817
Libardo J, Gómez RvW L, van Selm A, Rivera MC, Barbosa WH, van Brakel JA, Quintero W. Mitzi Waltz, and Karl Philipp Puchner. Stigma, participation restriction and mental distress in patients affected by leprosy, cutaneous leishmaniasis and Chagas disease: a pilot study in two co-endemic regions of eastern Colombia. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2019:1–7.
van Henten S, Adriaensen W, Fikre H, Akuffo H, Diro E, Hailu A, et al. Cutaneous Leishmaniasis due to Leishmania Aethiopica. EClinicalMedicine. 2018;6:69–81.
doi: 10.1016/j.eclinm.2018.12.009
pubmed: 31193672
Teshome M. Climate variability, communities’ perceptions and land management strategies in Lay Gayint Woreda. Northwest Ethiopia J Degraded Min Lands Manage. 2018;5:1217–35.
doi: 10.15243/jdmlm.2018.053.1217
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–6.
doi: 10.1111/j.1365-2230.1994.tb01167.x
pubmed: 8033378
Bennis I, De Brouwere V, Belrhiti Z, Sahibi H, Boelaert M. Psychosocial burden of localised cutaneous leishmaniasis: a scoping review. BMC Public Health. 2018;18(1):358.
doi: 10.1186/s12889-018-5260-9
pubmed: 29544463
pmcid: 5855994
Vares B, Mohseni M, Heshmatkhah A, Farjzadeh S, Safizadeh H, Shamsi-Meymandi S, et al. Quality of life in patients with cutaneous leishmaniasis. Arch Iran Med. 2013;16(8):474–7.
pubmed: 23906253
Chahed MK, Bellali H, Ben Jemaa S, Bellaj T. Psychological and psychosocial consequences of zoonotic cutaneous leishmaniasis among women in Tunisia: preliminary findings from an exploratory study. PLoS Negl Trop Dis. 2016;10(10):e0005090.
doi: 10.1371/journal.pntd.0005090
pubmed: 27788184
pmcid: 5082956
Bennis I, Belaid L, De Brouwere V, Filali H, Sahibi H, Boelaert M. The mosquitoes that destroy your face. Social impact of cutaneous leishmaniasis in South-eastern Morocco, a qualitative study. PLoS ONE. 2017;12(12):e0189906.
doi: 10.1371/journal.pone.0189906
pubmed: 29261762
pmcid: 5738074
Mohammad Ali Nilforoushzadeh HR, Jaffary F, Khatuni M. Comparison of quality of life in women suffering from cutaneous leishmaniasis treated with topical and systemic glucantime along with Psychiatric Consultation compared with the Group without. Psychiatric Consultation Skin Leishmaniasis 2010; 1(1).